Atul Ltd
Atul Ltd Q4 FY25 Results & Presentation Highlights: Revenue ₹5,583 Cr, PAT ₹499 Cr
Q4 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Atul Ltd's Q4 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). EBITDA (consolidated) for FY 2024-25: ₹1,022 crore, up 47% YoY; EBITDA margin improved to 18% from 15% - Operating margin (EBITDA %) (standalone) for FY 2024-25: 17%, increased 1 percentage point Yo
From Atul Ltd's Q4 FY25 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36).
- Standalone revenue from operations for 2024-25: ₹5,075 cr, 16% increase YoY from ₹4,358 cr in 2023-24 (Page 37).
- Crop Protection retail sales grew from 48 cr in 2021-22 to 71 cr in 2024-25 (Page 57).
- Sindica field activities volumes projected to grow from 91,000 in 2023-24 to 250,000 in 2025-26 (Page 59).
- Consolidated sales volume increased by 17% over 2023-24 (Page 15).
- Working capital rise aligns with sales volume increase (Page 40).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Atul Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Completed one RoI CAPEX with potential sales of ₹800 cr (Page 15).
- Capital expenditure trend shows ₹504 cr spent in 2023-24 and ₹270 cr in 2024-25 (Page 14).
- Atul Bioscience Ltd: Unlock value as both sites are USFDA inspected (zero 483 observations), 28 filings; enhancement of capacity for two products; establish two new products with intermediates; full capacity sales of three products; scale-up of two products right-first-time; process improvements for five products to release plant capacity; unrealised sales potential ₹145 cr (Page 62).
- Crop Protection – Bulk actives: Debottleneck capacities, increase utilization of newly commissioned plant, launch new products/formulations, expand regulatory approvals; unrealised sales potential ₹85 cr (Page 55).
- Atul Products Ltd: Increase capacity utilization with better efficiency; unrealised sales potential ₹200 cr (Page 48).
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Atul Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Atul Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.7K Cr, net profit ₹211 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
Others in Chemicals & Petrochemicals this season
- Vidhi Specialty Food Ingredients Ltd (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 investor presentation — and how it ran
- Chemcon Speciality Chemicals Ltd (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key investor presentation takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 investor presentation — and how it ranks agai
- Valiant Organics Ltd (Q4 FY25)
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…
- Clean Science (Q4 FY25)
2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.
Frequently Asked Questions
What were Atul Ltd Q4 FY25 results?
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). EBITDA (consolidated) for FY 2024-25: ₹1,022 crore, up 47% YoY; EBITDA margin improved to 18% from 15% - Operating margin (EBITDA %) (standalone) for FY 2024-25: 17%, increased 1 percentage point Yo
What is Atul Ltd share price analysis?
Atul Ltd currently shows a neutral. The stock trades at a P/E of 22.8 with a market cap of ₹18,167 Cr. Investors should review the full earnings analysis for detailed insights.
Is Atul Ltd planning capital expenditure?
Completed one RoI CAPEX with potential sales of ₹800 cr (Page 15).
Keep Atul Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.